Wells Fargo & Company »

Transcode Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Transcode Therapeutics (RNAZ) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Transcode Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Transcode Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transcode Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $474 55 8.62

More positions owned by Wells Fargo & Company

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Put Option (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Transcode Therapeutics

Geode Capital Management
UBS Group
Vanguard Capital Management
Vanguard Fiduciary Trust
Tower Research Capital
Wells Fargo & Company
SBI Securities
Royal Bank of Canada
Advisor Group Holdings

View all funds holding Transcode Therapeutics